SBME Faculty Candidate Seminar: John Hardy

SBME Faculty Candidate Seminar Series


Design of bioelectronic biomaterials for neuromodulation, drug delivery, tissue engineering and regenerative medicine.

Abstract: 

Stimuli-responsive biomaterials have significant potential for the development of systems capable of the controlled delivery of drugs/biologics, neuromodulation and tissue engineering. Our interest is in the design of smart biomaterials (particularly bioelectronics) capable of responding to one or more stimuli (typically electricity, light and magnetism), and demonstrating their efficacy in vitro/vivo. We employ an interdisciplinary approach (combining chemistry, materials science, biology, engineering and medicine) to generate bioelectronic biomaterials with task-specific properties, 3D printing non-degradable materials designed for neuromodulation (in vitro, ex vivo and in vivo), and developing degradable/transient electronics for drug delivery and tissue scaffolds to control cell behaviour. Integration of these materials in devices/tissues can enhance tissue regeneration offering economic, health and societal impacts. For more information about Dr. Hardy’s research, please visit Google Scholar.

Faculty Candidate

 

John Hardy

Department of Chemistry & Materials Science Institute, Lancaster University.

Bio: John completed his undergraduate studies in chemistry at the University of Bristol, followed by his PhD in the group of Prof. David Smith focused on biomaterials chemistry. He subsequently undertook a decade of interdisciplinary engineering-focused postdoctoral training overseas to broaden his scientific horizons: first as an Entente Cordiale Fellow in the lab of the Nobel Laureate Prof. Jean-Marie Lehn in France (Chemistry); then as an Alexander von Humboldt Fellow in the lab of Prof. Thomas Scheibel in Germany (Materials Science and Engineering); then as postdoctoral research associate in the lab of Prof. Christine Schmidt (Biomedical Engineering) first at the University of Texas at Austin and thereafter helping setup her new lab at the University of Florida in Gainesville (with a short sojourn in Prof. David Kaplan’s group at Tufts University in Medford); and finally as an Industrial Research Fellow in the lab of Prof. Colin McCoy (Pharmacy) at Queen’s University Belfast (UK), with a short sojourn in the labs of the industrial sponsors, Teleflex Inc., in Athlone (Ireland) and Boston (USA). He began his independent career as a 50th Anniversary Lecturer in Materials Chemistry at Lancaster University in August 2015 and is currently Senior Lecturer. During his time in the USA he developed the first examples of biodegradable electroactive polymer-based drug delivery devices, and biomaterials with biomimetic properties for drug delivery, neuromodulation and tissue engineering. He leads an interdisciplinary research group undertaking basic and applied research at the interface of biomedical and life sciences, chemistry, engineering and pharmacy, which focuses on employing a combination of bioprospecting and a biotechnology informed approach to biomaterials science and engineering for the generation of stimuli-responsive materials (particularly bioelectronics) for biomedical applications, and 3D printing in vivo.

For more information about Dr. Hardy’s research, please visit Google Scholar.

Research Group Website: https://sites.google.com/view/john-g-hardy-research-group/home


WHERE & WHEN

Date: May 17, 2022
Time: 10am (PDT)
Location (Hybrid):  LSC 1003 (LT3) | Zoom Meeting ID: 91783 244698, (Passcode: 244698)